Bank Of New York Mellon Corp Paratek Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $29,881 - $44,911	17,893 New	17,893 $33,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $4,282 - $6,402	-2,185 Reduced 10.88%	17,893 $46,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $202,437 - $361,579	-117,016 Reduced 85.35%	20,078 $39,000
Q1 2022 May 11, 2022	SELL	$2.94 - $4.77 $461 - $748	-157 Reduced 0.11%	137,094 $407,000
Q4 2021 Feb 11, 2022	SELL	$4.07 - $5.3 $11,835 - $15,412	-2,908 Reduced 2.07%	137,251 $616,000
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $59,746 - $92,034	12,712 Added 9.97%	140,159 $682,000
Q2 2021 Aug 11, 2021	SELL	$6.81 - $10.93 $19,313 - $30,997	-2,836 Reduced 2.18%	127,447 $869,000
Q1 2021 May 13, 2021	SELL	$6.14 - $8.31 $9,627 - $13,030	-1,568 Reduced 1.19%	130,283 $919,000
Q4 2020 Feb 09, 2021	SELL	$4.58 - $7.14 $6,279 - $9,788	-1,371 Reduced 1.03%	131,851 $825,000
Q3 2020 Nov 12, 2020	SELL	$4.19 - $6.69 $42,507 - $67,870	-10,145 Reduced 7.08%	133,222 $720,000
Q2 2020 Aug 12, 2020	BUY	$2.97 - $5.22 $68,259 - $119,971	22,983 Added 19.09%	143,367 $748,000
Q1 2020 May 06, 2020	SELL	$2.67 - $4.97 $590 - $1,098	-221 Reduced 0.18%	120,384 $379,000
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $23,674 - $36,360	8,080 Added 7.18%	120,605 $486,000
Q3 2019 Nov 07, 2019	BUY	$3.08 - $5.76 $14,494 - $27,106	4,706 Added 4.36%	112,525 $486,000
Q2 2019 Aug 12, 2019	SELL	$3.47 - $6.32 $120,325 - $219,152	-34,676 Reduced 24.33%	107,819 $430,000
Q1 2019 May 14, 2019	BUY	$5.36 - $7.24 $22,581 - $30,502	4,213 Added 3.05%	142,495 $764,000
Q4 2018 Feb 11, 2019	BUY	$4.8 - $11.6 $9,148 - $22,109	1,906 Added 1.4%	138,282 $710,000
Q3 2018 Nov 09, 2018	BUY	$9.05 - $10.95 $66,354 - $80,285	7,332 Added 5.68%	136,376 $0
Q2 2018 Aug 06, 2018	BUY	$10.2 - $13.9 $122,195 - $166,522	11,980 Added 10.23%	129,044 $1.32 Million
Q1 2018 May 15, 2018	SELL	$12.65 - $18.85 $680,380 - $1.01 Million	-53,785 Reduced 31.48%	117,064 $1.52 Million
Q4 2017 Feb 09, 2018	BUY	$17.45 - $25.6 $2.98 Million - $4.37 Million	170,849	170,849 $3.06 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account